PROFILE | ORGANIZATION | MANUFACTURING | PRODUCTS  | SALES  | NEWS | CONTACT
For more than sixty years, PROEL has been on the forefront of the Greek pharmaceutical industry. Our company's success lies on the constant emphasis on quality, growth and innovation. We share a common vision and we invest on this. PROEL's assets include a recently modernized manufacturing facility in Athens, state of the art laboratories as well as a portfolio of more than 70 licensed generic products for the Greek market and more than 50 in foreign countries. But our fundamental asset remains our human capital as well as our reputation in the industry and the business world.  PROEL remains open to propositions, new ideas and welcomes everybody to this web site which hopefully provides updated information about our activities and the products' portfolio.                                                 George Coronis                                                 CEO and Chairman	LIBRARY  REPORTS   LINKS   DIRECTORY   INTRANET
Pharmaceutical Industry PROEL EPAM. G. CORONIS SA - © 2007